Update of syncytiotrophoblast derived extracellular vesicles in normal pregnancy and preeclampsia.

Citation data:

Journal of reproductive immunology, ISSN: 1872-7603, Vol: 119, Page: 98-106

Publication Year:
Usage 14
Abstract Views 13
Link-outs 1
Captures 204
Readers 204
Social Media 12
Tweets 11
Shares, Likes & Comments 1
Citations 21
Citation Indexes 21
Tannetta, Dionne; Masliukaite, Ieva; Vatish, Manu; Redman, Christopher; Sargent, Ian
Elsevier BV
Medicine; Immunology and Microbiology
Most Recent Tweet View All Tweets
review description
The release of extracellular vesicles (EV) by the syncytiotrophoblast (STB) may be an important mechanism by which the placenta signals to the mother. STB derived EV (STBEV) are comprised predominantly of exosomes (50-150nm) and microvesicles (100-1000nm) that contain bioactive mediators such as proteins, nucleic acids and lipids. They, along with larger syncytial nuclear aggregates are released by the STB into the maternal circulation throughout gestation in normal pregnancy where they appear to have an immunoregulatory role, inhibiting T cell and NK cell responses. In pre-eclampsia (PE) STBEV are released in significantly increased numbers and have pro-inflammatory, anti-angiogenic and procoagulant activity, implicating them in the maternal systemic inflammation, endothelial dysfunction and activation of the clotting system which typifies the disorder. Research has focused on understanding the biological significance of STBEV by measuring their size and repertoire of molecules carried and how they differ in normal pregnancy and PE, using techniques such as Nanoparticle Tracking Analysis, flow cytometry and mass spectrometry. We have also found alterations in STBEV surface glycans associated with PE. The goal is to better understand the role STBEV play in normal pregnancy and PE and whether they are potential biomarkers of placental pathology and therapeutic targets in PE.